DPHARMA | DUOPHARMA BIOTECH BHD

6
1.86 (0.54%)

T-O: 1.85 (08:59:00)
Last updated: 17:00

Fundamental   7.0  
Technical   2.6  
Total Score   9.6  

 Insti+ 
DPHARMA | DUOPHARMA BIOTECH BHD

Fundamental

iSaham Fundamental Trend

FCON: 0.65 | Sharpe Ratio: 0.42 | LTS: 7.5


Quarter Reports

Trailing Dividend

Financial Ratios

EPS 8.97 sen
Trailing PE (Sector Median: 23.8) 27.7
PEG 1.44
Altman Z 1.3
Beaver 0.053
Current Ratio 2.33
Debt-Equity (DE) Ratio 0.79
FCF Yield -2.55 %
Revenue QoQ 8.45 %
Revenue YoY 1.22 %
Profit QoQ 4.49 %
Profit YoY 14.75 %
All-Time Profit Margin (Sector Median: 2.3) 16.4 %
ROE (ROIC: 7.12) 10.32 %
Dividend Per Share (DPS) 6.5 sen
Dividend Yield (DY) 3.49 %

Fair Value

Weighted Average Fair Value: 2.22

Discounted Cash Flow (DCF) 5% Growth 0.86
Discounted Cash Flow (DCF) 10% Growth 1.14
Relative Valuation 1.6
Average Analysts FV based on 4 rating(s), +52.7% 2.84
Graham Formula 0.71
Graham Number 1.39
Net Tangible Asset (NTA) 0.87
Consistent QR FV N/APremium Access Only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit 15.39
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 461.63
Expected Revenue (M) 4254.63
Expected Growth (%) 31.0

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Technical

Summary

Market Cap: 1751 M.

Number of Shares: 941 M.

Adjusted Float: 40.43%.

Stock highly correlated with

PHARMA (94%)

RGTBHD (93%)

SCOMNET (93%)

MENANG (92%)

Manipulation Indicator: Very hard to manipulate.

Sectors: Consumer Products, Healthcare, Pharmaceuticals, Technology, Budget 2021, Post MCO, Vaccine

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 25-Mar-2020

Shareholder Value (M)
Permodalan Nasional Berhad 590.59
Employees Provident Fund Board 106.3
Amanah Saham Bumiputera 55.8
Billion Victory Sdn Bhd 31.77
Public Islamic Treasures Growth Fund 13.41
Norges Bank 12.64
Manulife Investment Shariah Progressfund 12.55
Kumpulan Wang Persaraan (Diperbadankan) 9.5
Principal Dali Opportunities Fund 8.59
Eastspring Investmentssmall-Cap Fund 7.8
Manulife Investment Progress Fund 7.8
Lembaga Tabung Haji 7.48
Affin Hwang Aiiman Asia (Ex Japan) Growth Fund 6.26
Amanah Saham Malaysia 3 5.79
Tokio Marine Life Insurance Malaysia Bhd 5.27
Principal Islamic Small Cap Opportunities Fund 5.08
Affin Hwang Growth Fund 4.53
Ooi Keng Tan 4.1
CIMB-Principal Small Cap Fund 3.99
Petroliam Nasional Berhad 3.92
Gibraltar BSN Aggressive Fund 3.69
Affin Hwang Principled Growth Fund 3.68
Medical Fund 3.45
Credit Suisse 3.44
Amtotal Return 3.28
Hong Leong Assurance Berhad 3.2
Areca Equitytrust Fund 3.07